{"2503.06797": {"publish_time": "2025-03-09", "title": "Multimodal AI-driven Biomarker for Early Detection of Cancer Cachexia", "paper_summary": "Cancer cachexia is a multifactorial syndrome characterized by progressive\nmuscle wasting, metabolic dysfunction, and systemic inflammation, leading to\nreduced quality of life and increased mortality. Despite extensive research, no\nsingle definitive biomarker exists, as cachexia-related indicators such as\nserum biomarkers, skeletal muscle measurements, and metabolic abnormalities\noften overlap with other conditions. Existing composite indices, including the\nCancer Cachexia Index (CXI), Modified CXI (mCXI), and Cachexia Score (CASCO),\nintegrate multiple biomarkers but lack standardized thresholds, limiting their\nclinical utility. This study proposes a multimodal AI-based biomarker for early\ncancer cachexia detection, leveraging open-source large language models (LLMs)\nand foundation models trained on medical data. The approach integrates\nheterogeneous patient data, including demographics, disease status, lab\nreports, radiological imaging (CT scans), and clinical notes, using a machine\nlearning framework that can handle missing data. Unlike previous AI-based\nmodels trained on curated datasets, this method utilizes routinely collected\nclinical data, enhancing real-world applicability. Additionally, the model\nincorporates confidence estimation, allowing the identification of cases\nrequiring expert review for precise clinical interpretation. Preliminary\nfindings demonstrate that integrating multiple data modalities improves\ncachexia prediction accuracy at the time of cancer diagnosis. The AI-based\nbiomarker dynamically adapts to patient-specific factors such as age, race,\nethnicity, weight, cancer type, and stage, avoiding the limitations of\nfixed-threshold biomarkers. This multimodal AI biomarker provides a scalable\nand clinically viable solution for early cancer cachexia detection,\nfacilitating personalized interventions and potentially improving treatment\noutcomes and patient survival.", "paper_summary_zh": "<paragraph>\u764c\u75c7\u60e1\u75c5\u8cea\u662f\u4e00\u7a2e\u591a\u56e0\u7d20\u75c7\u5019\u7fa4\uff0c\u5176\u7279\u5fb5\u662f\u9032\u884c\u6027\u808c\u8089\u840e\u7e2e\u3001\u4ee3\u8b1d\u529f\u80fd\u969c\u7919\u548c\u5168\u8eab\u6027\u767c\u708e\uff0c\u5c0e\u81f4\u751f\u6d3b\u54c1\u8cea\u4e0b\u964d\u548c\u6b7b\u4ea1\u7387\u589e\u52a0\u3002\u5118\u7ba1\u9032\u884c\u4e86\u5ee3\u6cdb\u7684\u7814\u7a76\uff0c\u4f46\u7531\u65bc\u60e1\u75c5\u8cea\u76f8\u95dc\u6307\u6a19\uff08\u4f8b\u5982\u8840\u6e05\u751f\u7269\u6a19\u8a18\u3001\u9aa8\u9abc\u808c\u6e2c\u91cf\u503c\u548c\u4ee3\u8b1d\u7570\u5e38\uff09\u7d93\u5e38\u8207\u5176\u4ed6\u75be\u75c5\u91cd\u758a\uff0c\u56e0\u6b64\u4e26\u4e0d\u5b58\u5728\u55ae\u4e00\u7684\u660e\u78ba\u751f\u7269\u6a19\u8a18\u3002\u73fe\u6709\u7684\u7d9c\u5408\u6307\u6578\uff0c\u5305\u62ec\u764c\u75c7\u60e1\u75c5\u8cea\u6307\u6578 (CXI)\u3001\u6539\u826f CXI (mCXI) \u548c\u60e1\u75c5\u8cea\u8a55\u5206 (CASCO)\uff0c\u6574\u5408\u4e86\u591a\u7a2e\u751f\u7269\u6a19\u8a18\uff0c\u4f46\u7f3a\u4e4f\u6a19\u6e96\u5316\u7684\u95be\u503c\uff0c\u9650\u5236\u4e86\u5b83\u5011\u7684\u81e8\u5e8a\u61c9\u7528\u50f9\u503c\u3002\u672c\u7814\u7a76\u63d0\u51fa\u4e86\u4e00\u7a2e\u57fa\u65bc\u591a\u6a21\u614b AI \u7684\u751f\u7269\u6a19\u8a18\uff0c\u7528\u65bc\u65e9\u671f\u764c\u75c7\u60e1\u75c5\u8cea\u6aa2\u6e2c\uff0c\u5b83\u5229\u7528\u4e86\u958b\u6e90\u7684\u5927\u578b\u8a9e\u8a00\u6a21\u578b (LLM) \u548c\u57fa\u65bc\u91ab\u5b78\u6578\u64da\u8a13\u7df4\u7684\u57fa\u790e\u6a21\u578b\u3002\u8a72\u65b9\u6cd5\u4f7f\u7528\u53ef\u4ee5\u8655\u7406\u7f3a\u5931\u6578\u64da\u7684\u6a5f\u5668\u5b78\u7fd2\u6846\u67b6\uff0c\u6574\u5408\u4e86\u7570\u8cea\u60a3\u8005\u6578\u64da\uff0c\u5305\u62ec\u4eba\u53e3\u7d71\u8a08\u5b78\u8cc7\u6599\u3001\u75be\u75c5\u72c0\u614b\u3001\u5be6\u9a57\u5ba4\u5831\u544a\u3001\u653e\u5c04\u5f71\u50cf\u5b78\uff08CT \u6383\u63cf\uff09\u548c\u81e8\u5e8a\u8a18\u9304\u3002\u8207\u5148\u524d\u57fa\u65bc\u7b56\u5283\u6578\u64da\u96c6\u8a13\u7df4\u7684\u57fa\u65bc AI \u7684\u6a21\u578b\u4e0d\u540c\uff0c\u6b64\u65b9\u6cd5\u5229\u7528\u5e38\u898f\u6536\u96c6\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u589e\u5f37\u4e86\u73fe\u5be6\u4e16\u754c\u7684\u9069\u7528\u6027\u3002\u6b64\u5916\uff0c\u8a72\u6a21\u578b\u9084\u5305\u542b\u7f6e\u4fe1\u5ea6\u4f30\u8a08\uff0c\u5141\u8a31\u8b58\u5225\u9700\u8981\u5c08\u5bb6\u5be9\u67e5\u4ee5\u9032\u884c\u7cbe\u78ba\u81e8\u5e8a\u89e3\u91cb\u7684\u75c5\u4f8b\u3002\u521d\u6b65\u7814\u7a76\u7d50\u679c\u8868\u660e\uff0c\u6574\u5408\u591a\u7a2e\u6578\u64da\u6a21\u5f0f\u53ef\u4ee5\u63d0\u9ad8\u764c\u75c7\u8a3a\u65b7\u6642\u60e1\u75c5\u8cea\u9810\u6e2c\u7684\u6e96\u78ba\u6027\u3002\u57fa\u65bc AI \u7684\u751f\u7269\u6a19\u8a18\u6703\u6839\u64da\u60a3\u8005\u7684\u7279\u5b9a\u56e0\u7d20\uff08\u4f8b\u5982\u5e74\u9f61\u3001\u7a2e\u65cf\u3001\u6c11\u65cf\u3001\u9ad4\u91cd\u3001\u764c\u75c7\u985e\u578b\u548c\u5206\u671f\uff09\u9032\u884c\u52d5\u614b\u8abf\u6574\uff0c\u907f\u514d\u4e86\u56fa\u5b9a\u95be\u503c\u751f\u7269\u6a19\u8a18\u7684\u5c40\u9650\u6027\u3002\u9019\u7a2e\u591a\u6a21\u614b AI \u751f\u7269\u6a19\u8a18\u70ba\u65e9\u671f\u764c\u75c7\u60e1\u75c5\u8cea\u6aa2\u6e2c\u63d0\u4f9b\u4e86\u4e00\u7a2e\u53ef\u64f4\u5c55\u4e14\u81e8\u5e8a\u53ef\u884c\u7684\u89e3\u6c7a\u65b9\u6848\uff0c\u6709\u52a9\u65bc\u500b\u6027\u5316\u5e72\u9810\uff0c\u4e26\u53ef\u80fd\u6539\u5584\u6cbb\u7642\u7d50\u679c\u548c\u60a3\u8005\u5b58\u6d3b\u7387\u3002</paragraph>\n", "author": "Sabeen Ahmed et.al.", "authors": "Sabeen Ahmed, Nathan Parker, Margaret Park, Evan W. Davis, Jennifer B. Permuth, Matthew B. Schabath, Yasin Yilmaz, Ghulam Rasool", "id": "2503.06797v1", "paper_url": "http://arxiv.org/abs/2503.06797v1", "repo": "null"}}